Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Biocryst Pharmaceuticals Inc (BCRX)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 12,710,818 | $206,678 | 1.18% | |
| 2. | Fisher Asset Management Ken Fisher | 3,986,823 | $64,826 | -3% | 0.03% |
| 3. | VenBio Select Advisor Kurt Von Emster | 1,875,000 | $30,488 | 0.55% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 1,771,012 | $28,797 | -18% | 0.07% |
| 5. | Sarissa Capital Management Alex Denner | 1,390,790 | $22,614 | -66% | 2.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.19 | 7,500 | Director | 17,500 | 2021-11-24 | Filing | |
| $12.48 | 35,258 | Officer | 93,719 | 2021-11-23 | Filing | |
| $4.08 | 54,000 | Officer | 54,000 | 2020-08-11 | Filing | |
| $1.45 | 50,000 | Officer, Director | 778,086 | 2019-11-18 | Filing | |
| $1.45 | 45,000 | Officer | 45,000 | 2019-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.04 | 5,000 | Director | 0 | 2022-04-18 | Filing | |
| $16.20 | 7,600 | Officer | 136,400 | 2022-04-01 | Filing | |
| $17.64 | 1,400 | Officer | 37,954 | 2022-03-10 | Filing | |
| $16.87 | 159,739 | Officer | 39,354 | 2022-03-10 | Filing | |
| $17.16 | 20,000 | Officer | 230,056 | 2022-03-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 231,150 | $3,758,499 | 0% | |
| 2. | 117,505 | $1,910,631 | 0.01% | |
| 3. | 43,800 | $712,000 | 0.01% | |
| 4. | 25,845 | $420,240 | 0% | |
| 5. | 14,101,975 | $229,298 | 0% |
News See All
10 Biotech Stocks to Buy Today According to Ken Fisher
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
Do Hedge Funds Love BioCryst Pharmaceuticals, Inc. (BCRX)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
15 Good Stocks to Buy Right Now
Investors are practicing extreme caution amid uncertainty caused by the resurgence of COVID-19 all over the world.
5 Biotech Stocks Popular On Reddit
Agenus Inc. (NASDAQ: AGEN) ranks 5th on the list of 11 biotech stocks popular on Reddit. The Massachusetts-based biotech firm develops immuno-oncology therapeutics.
Is BioCryst Pharmaceuticals, Inc. (BCRX) Going to Burn These Hedge Funds?
A whopping number of 13F filings filed with U.S.
Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Is BCRX Stock A Buy or Sell?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
10 Best Small-Cap Biotech Stocks Under $10 in 2021
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
Billionaire Hedge Funds
